ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 127 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,215,000 | +185.2% | 23,415 | +310.8% | 0.01% | +150.0% |
| Q4 2021 | $426,000 | +68.4% | 5,700 | +15.7% | 0.00% | -75.0% |
| Q1 2020 | $253,000 | -15.9% | 4,925 | -23.4% | 0.02% | -40.7% |
| Q3 2017 | $301,000 | +4.5% | 6,427 | -31.2% | 0.03% | -6.9% |
| Q1 2017 | $288,000 | -5.0% | 9,336 | -17.9% | 0.03% | -43.1% |
| Q3 2016 | $303,000 | -8.5% | 11,376 | -24.2% | 0.05% | -31.1% |
| Q2 2016 | $331,000 | -7.0% | 15,015 | +24.0% | 0.07% | -49.0% |
| Q1 2016 | $356,000 | – | 12,108 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |